Neuroprotective effect of H. perforatum extracts on β-amyloid-induced neurotoxicity

Neurotoxicity Research

Volumn 6, Issue 2, 2004, Pages 119-130

  Silva, Bruno A ^a,b   Dias, Alberto C P ^b   Ferreres, Federico ^c   Malva, João O ^a   Oliveira, Catarina R ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF MINHO   (Portugal)

^c RESEARCH GROUP ON QUALITY   (Spain)

Author keywords

Alzheimer's disease; Amyloid (25 35); Hippocampal neurons; Hypericum perforatum; Neuroprotection

Indexed keywords

AMYLOID BETA PROTEIN; NEUROPROTECTIVE AGENT; PLANT EXTRACT;

ANIMAL; ARTICLE; CELL CULTURE; CELL DEATH; CELL SURVIVAL; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; HIPPOCAMPUS; HYPERICUM; ISOLATION AND PURIFICATION; METABOLISM; PATHOLOGY; PHYSIOLOGY; PLANT; RAT; WISTAR RAT;

AMYLOID BETA-PROTEIN; ANIMALS; CELL DEATH; CELL SURVIVAL; CELLS, CULTURED; HIPPOCAMPUS; HYPERICUM; NEUROPROTECTIVE AGENTS; PLANT COMPONENTS, AERIAL; PLANT EXTRACTS; RATS; RATS, WISTAR;

EID: 4644288341     PISSN: 10298428     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03033214     Document Type: Article

References (48)

1. Agostinho P and CR Oliveira (2003) Involvement of calcineurin in the neurotoxic effects induced by amyloid-beta and prion pep-tides. Eur. J. Neurosci. 17, 1189-1196.
2. Ahlemeyer B and J Krieglstein (2003) Neuroprotective effects of Ginkgo biloba extract. Cell. Mol. Life Sci. 60, 1779-1792.
3. Alvarez G, M Ramos, F Ruiz, J Satrustegui and E Bogonez (2003) Pyruvate protection against beta-amyloid-induced neuronal death: Role of mitochondrial redox state. J. Neurosci. Res. 73, 260-269.
4. i changes in cultured rat hippocampal neurons. Eur. J. Neurosci. 12, 2021-2031.
5. Areias FM, AC Rego, CR Oliveira and RM Seabra (2001) Antioxidant effect of flavonoids after ascorbate/Fe(2+)-induced oxidative stress in cultured retinal cells. Biochem. Pharmacol. 62, 111-118.
6. Bains JS and CA Shaw (1997) Neurodegenerative disorders in humans: The role of glutathione in oxidative stress-mediated neuronal death. Brain Res. Rev. 25, 335-358.
7. Bastianetto S and R Quirion (2002) Natural extracts as possible protective agents of brain aging. Neurobiol. Aging 23, 891-897.
8. Behl C and B Moosmann (2002) Antioxidation neuroprotection in Alzheimer's disease as preventive and therapeutic approach. Free Radic. Biol. Med. 33, 182-191.
9. Brewer GJ, JR Torricelli, EK Evege and PJ Price (1993) Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum-free medium combination. J. Neurosci. Res. 25, 567-576.
10. Butterweck V (2003) Mechanisms of action of St John's wort in depression. CNS Drugs 17, 539-562.
11. Cakir A, A Mavi, A Yildirim, ME Duru, M Harmandar and C Kazaz (2003) Isolation and characterization of antioxidant phenolic compounds from the aerial parts of Hypericum hyssopifolium L. by activity-guided fractionation. J. Ethnopharmacol. 87, 73-83.
12. Casley CS, JM Land, MA Sharpe, JB Clark, MR Duchen and L Canevari (2002) Beta-amyloid fragment 25-35 causes mitochondrial dysfunction in primary cortical neurons. Neurobiol. Dis. 10, 258-267.
13. Conforti F, GA Statti, R Tundis, F Menichini and P Houghton (2002) Antioxidant activity of methanolic extract of Hypericum triquetrifolium Turra aerial part. Fitoterapia 73, 479-483.
14. Cotman CW and JH Su (1996) Mechanisms of neuronal death in Alzheimer's disease. Brain Pathol. 6, 493-506.
15. Di Carlo G, F Borrelli, E Ernst and AA Izzo (2001) St John's wort: prozac from the plant kingdom. Trends Pharmacol. Sci. 22, 292-297.
16. Dias ACP, RM Seabra, PB Andrade, F Ferreres and MF Ferreira (1999) The development and evaluation of a HPLC-DAD method for the analysis of the phenolic fractions from in vivo and in vitro biomass of Hypericum species. J. Liquid Chromatography & R.T. 22, 215-217.
17. Du HY, M Olivo, BK Tan and BH Bay (2003) Hypericin-mediated photodynamic therapy induces lipid peroxidation and necrosis in nasopharyngeal cancer. Int. J. Oncol. 23, 1401-1405.
18. Erdelmeier CAJ, E Koch and R Hoerr (2000) Hypericum perforatum - St. John's wort chemical, pharmacological and clinical aspects, In: Atta-ur-Rahman (Ed.) Studies in Natural Products Chemistry - Bioactive Natural Products (Part C) (Elsevier Direct: New York), Vol. 22, pp. 643-716.
19. Greeson JM, B Sanford and DA Monti St, (2001) St. John's wort (Hypericum perforatum): A review of the current pharmacological, toxicological, and clinical literature. Psychopharmacology 153, 402-414.
20. Hensley K, JM Carney, MP Mattson, M Aksenova, M Harris, JF Wu, RA Floyd and DA Butterfield (1994) A model for Β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: Relevance to Alzheimer disease. Proc. Natl. Acad. Sci. USA 94, 3270-3274.
21. Hunt EJ, CE Lester, EA Lester and RL Tackett (2002) Effect of St. John's wort on free radical production. Life Sci. 69, 181-190.
22. Jellinger KA (2001) Cell death mechanisms in neurodegeneration. J. Cell. Mol. Med. 5, 1-17.
23. Malva JO, AP Vieira and CR Oliveira (2003) Understanding physiology of glutamate receptors by use of a protocol for neuronal staining. Adv. Physiol. Edu. 27, 78-85.
24. Mattson MP (1997) Central role of oxyradicals in the mechanism of amyloid β-peptide cytotoxicity. Alzheimer Dis. Rev. 2, 1-14.
25. Mattson MP, J Partin and JG Begley (1998) Amyloid β-peptide induced apoptosis-related events in synapses and dendrites. Brain Res. 807, 167-176.
26. 3H]acetylcholine release in retinal neurons. Involvement of metabolic dysfunction. Amyloid 9, 221-228.
27. Mook-Jung I, H Kim, W Fan, Y Tezuka, S Kadota, H Nishijo and MW Jung (2002) Neuroprotective effects of constituents of the oriental crude drugs, Rhodiola sacra, R. sachalimensis and Tokaku-joki-to against β-amyloid toxicity, oxidative stress and apoptosis. Biochem. Pharmacol. Bull. 25, 1101-1104.
28. Moreira PI, MS Santos, A Moreno and CR Oliveira (2001) Amyloid β-peptide promotes permeability transition pore in brain mitochondria. Biosci. Rep. 21, 789-800.
29. Moreira PI, MS Santos, AM Moreno and R Seica and CR Oliveira (2003) Increased vulnerability of brain mitochondria in diabetic (Goto-Kakizaki) rats with aging and amyloid-β exposure. Diabetes 52, 1449-1556.
30. Morimoto K and T Oda (2003) Kainate exacerbates β-amyloid toxicity in rat hippocampus. Neurosci. Lett. 340, 242-244.
31. Muller WE, A Singer, M Wonnemann, U Hafner, M Rolliand and C Schafer (1998) Hyperforin represents the neurotransmitter reup-take inhibiting constituent of hypericum extract. Pharmacopsychiatry 31(Suppl 1): S16-S21.
32. Nahrstedt A and V Butterweck (1997) Biologically active and other chemical constituents of the herb of Hypericum perforatum L. Pharmacopshychiatry 30, 129-134.
33. Pereira C, MS Santos and CR Oliveira (1999) Involvement of oxidative stress on the impairment of energy metabolism induced by A beta peptides on PC12 cells: Protection by antioxidants. Neurobiol. Dis. 6, 209-219.
34. Pereira CF, P Moreira, R Seica, MS Santos and CR Oliveira (2000) Susceptibility to beta-amyloid-induced toxicity is decreased in goto-kakizaki diabetic rats: Involvement of oxidative stress. Exp. Neurol. 161, 383-391.
35. Prior RL (2003) Fruits and vegetables in the prevention of cellular oxidative damage. Am. J. Clin. Nutr. 78 (3 Suppl): 570S-578S.
36. Raina AK, A Hochman, X Zhu, CA Rottkamp, A Nunomura, SL Siedlak, H Boux, RJ Castellani, G Perry and MA Smith (2001) Abortive apoptosis in Alzheimer's disease. Acta Neuropathol. (Berl.) 101, 305-310.
37. Rego AC, N Monteiro, AP Silva, JO Malva and RO Catarina (2003) Mitochondrial apoptotic cell death and moderate superoxide generation upon selective activation of non-desensitizing AMPA receptors in hippocampal cultures. J. Neurochem. 86, 792-804.
38. Schempp CM, V Kirkin, B Simon-Haarhaus, A Kersten, J Kiss, CC Termeer, B Gilb, T Kaufmann, C Borner, JP Sleeman and JC Simon (2002) Inhibition of tumour cell growth by hyperforin, a novel anticancer drug from St. John's wort that acts by induction of apoptosis. Oncogene 21, 1242-1250.
39. Silva AP, AP Carvalho, CM Carvalho and JO Malva (2001) Modulation of intracellular calcium changes and glutamate release by neuropeptide Y1 and Y2 receptors in the rat hippocampus: Differential effects in CA1, CA3 and dentate gyrus. J. Neurochem. 79, 286-296.
40. Silva BC and ACP Dias (2002) Evaluation of the free radical scavenger activity of Hypericum perforatum alcoholic extracts. Revista de Fitoterapia 2 (Suppl. 1): P. 133.
41. Small DH and CA McLean (1999) Alzheimer's disease and the amyloid β-protein: What is the role of amyloid? J. Neurochem. 73, 443-449.
42. Tomiyama T, A Shoji, K Kataoka, Y Suwa, S Asano, H Kaneko and N Endo (1996) Inhibition of amyloid β-protein aggregation and neurotoxicity by rifampicin. J. Biol. Chem. 12, 6839-6844.
43. Valentão P, E Fernandes, F Carvalho, PB Andrade, RM Seabra and ML Bastos (2002) Antioxidant activity of Hypericum androsae-mum infusion: scavenging activity against superoxide radical, hydroxyl radical and hypochlorous acid. Biol. Pharm. Bull. 25, 1320-1323.
44. Vila M and S Przedborski (2003) Targeting programmed cell death in neurodegenerative diseases. Nat. Rev. Neurosci. 4, 365-375.
45. Ward MW, AC Rego, BG Frenguelli and DG Nicholls (2000) Mitochondrial membrane potential and glutamate excitotoxicity in cultured cerebellar granule cells. J. Neurosci. 20, 7208-7219.
46. Yankner B (1996) Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 16, 921-932.
47. Youdim KA and JA Joseph (2001) A possible emerging role of phytochemicals in improving age-related neurological dysfunctions: A multiplicity of effects. Free Radic. Biol. Med. 30, 583-594.
48. Youdim KA, JP Spencer, H Schroeter and C Rice-Evans (2002) Dietary flavonoids as potential neuroprotectants. Biol. Chem. 383, 503-519.